Question follow-through · 55214

Diabetes: Eating Disorders

To ask the Secretary of State for Health and Social Care, whether he has made an assessment of the potential impact of the abolition of NHS England on Type 1 Diabetes with Disordered Eating pilots.

answeredDepartment of Health and Social Care

About this written question

A written question asks a government minister for information in writing. Parliament publishes the question and any answer.

Answering body
Department of Health and Social Care
Tabled
30 May 2025
Target answer date
3 Jun 2025
Answer
6 Jun 2025 · 7 calendar days after tabling

Elapsed calendar days describe the record timeline, not whether Parliament considers an answer on time.

More questions by this MP on Health and care

Shared topic keywords suggest a connection; they do not establish a follow-up.

Votes on this topic

These Commons divisions share a topic label. The question did not necessarily lead to a vote.

Recorded timeline

  1. 30 May 2025

    Question tabled

    To ask the Secretary of State for Health and Social Care, whether he has made an assessment of the potential impact of the abolition of NHS England on Type 1 Diabetes with Disordered Eating pilots.

  2. 3 Jun 2025

    Target answer date

    Date supplied by the official written-questions record.

  3. 6 Jun 2025

    Answer published

    As we work to bring NHS England and the Department together, we will ensure that we continue to evaluate impacts of all kinds and will put plans in place to ensure continuity of care. For 2025/26, national funding has been made available to support delive...

Open official record

Official data retrieved 28 Sept 2026.

Later records

Possible follow-up questions

Strong links require the same MP, department and exact heading. Other same-department questions are shown as unreviewed candidates, not as confirmed follow-ups. No debate link is asserted unless a stable source relationship exists.

Unreviewed candidateSame MP and department; topic relationship is unreviewed

Visual Impairment: Rehabilitation

25 Nov 2025 · To ask the Secretary of State for Health and Social Care, if he will make an assessment of recent trends in the number of patients receiving timely access to vision rehabilitation services in line with industry best practice.

Unreviewed candidateSame MP and department; topic relationship is unreviewed

Visual Impairment: Rehabilitation

25 Nov 2025 · To ask the Secretary of State for Health and Social Care, what assessment his Department has made of (a) the effect of no national oversight relating to the quality of vision rehabilitation services for patients in England and (b) the experiences of those

Unreviewed candidateSame MP and department; topic relationship is unreviewed

Visual Impairment: Rehabilitation

25 Nov 2025 · To ask the Secretary of State for Health and Social Care, what steps his Department is taking to secure a sustainable future for the vision rehabilitation workforce.

Unreviewed candidateSame MP and department; topic relationship is unreviewed

NHS: Drugs

4 Dec 2025 · To ask the Secretary of State for Health and Social Care, what assessment he has made of the potential impact of the 25% net increase in prices for new medicines and the 15% VPAG repayment cap on annual NHS medicines spend.

Unreviewed candidateSame MP and department; topic relationship is unreviewed

NHS: Drugs

4 Dec 2025 · To ask the Secretary of State for Health and Social Care, from which Department’s budget the additional NHS medicines spend following the UK-US Economic Prosperity Deal will be funded.

Unreviewed candidateSame MP and department; topic relationship is unreviewed

NHS: Drugs

5 Dec 2025 · To ask the Secretary of State for Health and Social Care, whether the capped VPAG rate referred to in the UK-US Economic Prosperity Deal will only apply to pharmaceutical products of US origin.

Unreviewed candidateSame MP and department; topic relationship is unreviewed

NHS: Drugs

10 Dec 2025 · To ask the Secretary of State for Health and Social Care, whether the UK is (a) excluded from, (b) partially exempted from and (c) otherwise subject to special treatment under the United States’ Most Favoured Nation drug pricing policy.

Unreviewed candidateSame MP and department; topic relationship is unreviewed

Life Sciences

4 Feb 2026 · To ask the Secretary of State for Health and Social Care, with reference to the correspondence from the Minister for Science, Innovation, Research and Nuclear to the Chair of the Science, Innovation and Technology Committee, dated 30 January 2026, if he w